Genome Canada

Genome Canada is a not-for-profit organisation, established on February 8, 2000 in the wake of the international Human Genome Project, that acts as a catalyst for large-scale genomics research and its application to sectors of strategic importance to Canada — health, agriculture and agri-food, fisheries and aquaculture, forestry, energy, mining, and the environment. It is funded primarily by the federal government through Innovation, Science and Economic Development Canada, but operates as an independent organisation rather than a government department, and its funding model is structurally different from a direct-to-investigator grant program like NSERC’s Discovery Grant.

How Genome Canada Funds Research

Rather than accepting applications and disbursing grants directly from a single national office, Genome Canada operates through a network of six regional Genome Centres, each aligning national research priorities with regional research strengths and industry needs: Genome British Columbia, Genome Alberta, Genome Prairie (serving Manitoba and Saskatchewan), Ontario Genomics, Genome Quebec, and Genome Atlantic (serving Nova Scotia, New Brunswick, Prince Edward Island, and Newfoundland and Labrador). A research team’s practical entry point into Genome Canada funding is usually its relevant regional centre, not Genome Canada’s national office directly.

Major Funding Competitions

Genome Canada runs several large-scale, mission-driven funding competitions rather than a single standing grant program:

• Large-Scale Applied Research Project (LSARP) Competition — funds large genomics-based projects addressing challenges in one of Canada’s major economic sectors, run under rotating themes such as genomics and personalized health, or genomic solutions for natural resources, the environment, agriculture, or aquaculture.
• Genomic Applications Partnership Program (GAPP) — funds research and development projects that pair academic researchers with an industry partner to translate genomics research into a commercial application.
• Natural Resources Initiative — applies genomics approaches to the management of Canada’s natural resources and biodiversity.

A cross-cutting feature of Genome Canada-funded work is its formal attention to the ethical, environmental, economic, legal, and social aspects of genomics research, referred to as GE³LS — funded projects above a certain scale are expected to budget for this dimension explicitly rather than treat it as an afterthought.

Co-Funding Requirements

Genome Canada funding is co-funded by design, not by exception: a project typically needs to secure a substantial share of its total cost from partners outside Genome Canada itself. A common benchmark is a minimum 1:1 co-funding ratio — at least one dollar from other sources for every dollar Genome Canada contributes — though the exact split varies by program; under GAPP specifically, Genome Canada may fund up to one-third of project costs, with the industry partner and other sources covering the remaining two-thirds. Eligible co-funding can be cash or in-kind, and can come from provincial governments, industry partners, or other non-profit organisations, in addition to the applicant institution itself.

How It Differs from Tri-Agency Funding

Genome Canada sits outside the Tri-Agency (CIHR, NSERC, SSHRC) funding structure entirely — it is not a fourth granting council, and a research office should not expect Tri-Agency application mechanics, deadlines, or peer-review processes to carry over. Where a Tri-Agency grant like an NSERC Discovery Grant or a CIHR project grant typically funds an individual investigator’s or small team’s research program directly from a national competition, Genome Canada funding is large-scale, sector-targeted, routed through a regional Genome Centre, and structurally co-funded by outside partners as a condition of the award rather than as an added strength. A genomics researcher whose work fits a current LSARP or GAPP theme and who can bring a co-funding partner to the table is the intended applicant; a researcher seeking standard operating-grant funding for an investigator-driven genomics project is better served by the relevant Tri-Agency program.